A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.

scientific article published on May 2003

A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1033819251
P356DOI10.1023/A:1023351819956
P698PubMed publication ID12779076
P5875ResearchGate publication ID10732453

P50authorIlpo HuhtaniemiQ27588685
Adam ZięcikQ59161130
P2093author name stringRabah Soliymani
Gabriel Bodek
William Hansel
Monika Zaleska
Hikka Lankinen
Nafis Ahmed Rahman
P2860cites workTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyQ28283241
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancerQ33765709
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and geneticsQ33801855
Molecular targets for breast cancer therapy and preventionQ33944781
Antibiotic peptides as mediators of innate immunityQ33987884
Antibacterial peptides: key components needed in immunityQ34098783
Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channelsQ34126752
Glycoprotein Hormones: Structure and FunctionQ34252688
Antibacterial peptides from pig intestine: isolation of a mammalian cecropinQ34322042
Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesisQ35983173
Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesisQ35993752
Recombinant Toxins for Cancer TreatmentQ36533609
The actions of melittin on membranesQ37923509
Endocrine treatment of breast cancer in womenQ37938852
Targeted toxin therapy for the treatment of cancerQ38288386
Immunotoxins: a clinical review of their use in the treatment of malignanciesQ38725006
Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancerQ41079089
The mouse inhibin alpha-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic miceQ41197122
Annual hazard rates of recurrence for breast cancer after primary therapy.Q50616854
Human chorionic gonadotropin and rat mammary cancer prevention.Q53506326
Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro.Q55065991
Fluorescence, CD, attenuated total reflectance (ATR) FTIR, and 13C NMR characterization of the structure and dynamics of synthetic melittin and melittin analogues in lipid environmentsQ67748016
Epidemiology of breast cancerQ68675547
Evidence for the presence of luteinizing hormone/human chorionic gonadotropin-binding sites in the porcine uterusQ70143999
A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG)Q72330395
Targeted approaches to cancer therapyQ72668361
The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glandsQ73208294
Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptorsQ73422184
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)1-10
P577publication date2003-05-01
P1433published inBreast Cancer Research and TreatmentQ326085
P1476titleA novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate
P478volume79

Reverse relations

cites work (P2860)
Q34768470A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
Q34116325Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
Q37218593LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment
Q38250517Nanoparticulate carriers: an emerging tool for breast cancer therapy
Q36026107Nongonadal LH receptors, their involvement in female reproductive function and a new applicable approach.
Q33672433Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.
Q50885951Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease?
Q50878191Seasonal expressions of follicle-stimulating hormone receptor and luteinizing hormone receptor in the scented gland of the male muskrat (Ondatra zibethicus).
Q37229453Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer

Search more.